Postdoctoral Scholar
Medical Immunology · Iran · 2023-01-21
Proposed Endeavor
The petitioner proposes to continue research on engineering and enhancing T lymphocytes to produce anti-tumoral proteins during radiotherapy to improve cancer treatment. This work involves employing advanced biotechnical tools and genetic manipulation techniques to uncover neurodegenerative mechanisms and develop novel therapies for cancer diseases.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses cancer, the second leading cause of death in the U.S., and provides innovative treatments.
The petitioner has 10 years of experience, a strong publication record with 363 citations, and has received NIH funding.
On balance, the petitioner's expertise in oncology and immunology makes her work beneficial to the U.S. national interest.
Why This Petition Was Approved
Evidence
Similar Cases
Postdoctoral Researcher
Biotechnology · China
Research Scientist
Biotechnology · Taiwan
Postdoctoral Researcher
Biotechnology · Mexico
Others
Biotechnology · Iran
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-21.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist